Voyager Therapeutics is providing unrestricted funds for the support of several educational activities related to Huntington's Disease throughout 2021. These activities are intended to educate and support HD patients and their families.
|Effective start/end date||3/1/21 → 2/28/22|
- Voyager Therapeutics, Inc. (Award Letter 3/12/21)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.